Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
-
David Ray
Professor of Endocrinology, Head of OCDEM, and Co-Director Sir Jules Thorn Sleep and Circadian Neuroscience Institute
Latest publications
-
Causal inference in health and disease: a review of the principles and applications of Mendelian randomization.
Journal article
Lovegrove CE. et al, (2024), J Bone Miner Res
-
Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain
Preprint
Hodson D. et al, (2024)
-
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
Journal article
Smith K. et al, (2024), Diabetologia
-
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD.
Journal article
Colosimo S. et al, (2024), Diabetes Res Clin Pract
Latest News
Jeremy Tomlinson awarded Outstanding Chief Investigator in NIHR celebration
23 July 2024
Congratulations to Professor Jeremy Tomlinson on winning an award for ‘Outstanding Chief Investigator’ from the National Institute of Health and Care Research’s (NIHR) Thames Valley and South Midlands Clinical Research Network (LCRN).
Senior Fellowship awarded to Costas Christodoulides
4 July 2024
Congratulations to Costas Christodoulides, who has been awarded a Senior Clinical Research Fellowship with the British Heart Foundation.
Professor Rajesh Thakker receives OBE in King’s Birthday Honours
17 June 2024
Congratulations to RDM’s Professor Rajesh Vasantlal Thakker FRS, May Professor of Medicine and lately President, Society for Endocrinology, who has been appointed Officer of the Order of the British Empire (OBE) in the King’s Birthday Honours 2024.
The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment
16 April 2024
The first participant has completed initial study activities and is now randomised to one of the trial’s arms.
OCDEM Vacancies
Events
View previous and upcoming events in OCDEM.